Pasithea Therapeutics
KTTA
KTTA
8 hedge funds and large institutions have $99.1K invested in Pasithea Therapeutics in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
59% less capital invested
Capital invested by funds: $243K → $99.1K (-$144K)
Holders
8
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$66.4K | |
| 2 | +$17.8K | |
| 3 | +$4.8K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.79K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AI
1
AdvisorShares Investments
Bethesda,
Maryland
| $66.4K |
|
|||
2
Citigroup
New York
| $17.8K |
|
|||
3
UBS Group
Zurich,
Switzerland
| $5.64K |
|
|||
|
HC
4
Hurley Capital
New York
| $4.8K |
|
|||
|
TRCT
5
Tower Research Capital (TRC)
New York
| $4.25K |
|
|||
6
JPMorgan Chase & Co
New York
| $195 |
|
|||
7
Bank of America
Charlotte,
North Carolina
| $10 |
|
|||
|
AC
8
Armistice Capital
New York
| – |
|
|||
9
Morgan Stanley
New York
| – |
|